Search Options Stock News and Analysis from Schaeffer's

SEARCH RESULTS FOR: "Tag: EDIT"

REFINE YOUR SEARCH

REFINE YOUR SEARCH:

ARTICLES/BLOGS

2019(1)

2018(4)

2017(2)

CATEGORIES

Analyst Update(2)

Buzz Stocks(1)

Midday Market Check(1)

Opening View(1)

Stocks On the Move(2)

Unusual Trading Activity(1)

BTIG Targets 50% Upside for 2 Gene Editing Stocks

https://www.schaeffersresearch.com/content/news/2019/02/08/btig-targets-50-upside-for-2-gene-editing-stocks

2/8/2019 11:27 AM

BTIG is chiming in on healthcare names today, and for gene editing stocks Editas Medicine Inc (NASDAQ:EDIT) and Intellia Therapeutics Inc (NASDAQ:NTLA), this resulted in fresh "buy" ratings and impr...

Raymond James Picks Editas Medicine Over Gene Editing Rival

https://www.schaeffersresearch.com/content/news/2018/09/21/raymond-james-picks-editas-medicine-over-gene-editing-rival

9/21/2018 9:24 AM

Gene editing stocks have cooled in recent months after a big start to 2018. However, CRISPR Therapeutics AG (NASDAQ:CRSP) and Editas Medicine Inc (NASDAQ:EDIT) are back in focus today following anal...

Gene Editing Stocks Pull Back On New CRISPR Study

https://www.schaeffersresearch.com/content/news/2018/07/16/gene-editing-stocks-pull-back-on-new-crispr-study

7/16/2018 2:28 PM

U.S. stocks are sluggish today, as lower oil prices weigh on the major indexes. One group in particular that's under pressure is gene editing stocks, following another concerning study on CRISP/Ca...

VIX Spikes as Stocks Stay Lower with Apple

https://www.schaeffersresearch.com/content/ezines/2018/01/29/vix-spikes-as-stocks-stay-lower-with-apple

1/29/2018 12:05 PM

Stocks are pulling back, with the Dow Jones Industrial Average (DJI) dropping more than 160 points at its intraday low -- pressured by Apple's (AAPL) iPhone X production concerns ahead of Thursday...

Gene Editing Stocks Surge On First Trading Day of 2018

https://www.schaeffersresearch.com/content/news/2018/01/02/gene-editing-stocks-surge-on-first-trading-day-of-2018

1/2/2018 4:41 PM

In our Midday Market Check newsletter, we highlighted the huge move from Switzerland-based gene editing firm Crispr Therapeutics (CRSP), but that was just part of a much larger theme today. A number ...

PEOPLE ALSO SEARCH FOR